NCT02418767View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions
Growth Hormone Deficiency
Interventions
DRUG

MOD-4023

DRUG

Placebo

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors

Collaborators (1)

WCCT Global
All Listed Sponsors
collaborator

WCCT Global

INDUSTRY

lead

OPKO Health, Inc.

INDUSTRY

NCT02418767 - Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers | Biotech Hunter | Biotech Hunter